Form 8-K - Current report:
SEC Accession No. 0001004878-17-000033
Filing Date
2017-02-13
Accepted
2017-02-13 15:40:52
Documents
1
Period of Report
2017-02-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K RE FDA MEETING form8kfda2-17.txt 8-K 3146
  Complete submission text file 0001004878-17-000033.txt   4285
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 17598758
SIC: 2836 Biological Products, (No Diagnostic Substances)